Live
FierceBiotechTakeda 0 for 4 against nausea and vomiting after axing another assetLabiotechTIL therapies: the impact on cancer researchFierceBiotechAstraZeneca pens agentic AI licensing deal with Owkin10x Genomics BlogIs It Time To Reassess 10x Genomics (TXG) After Its Recent Share Price Surge? - Yahoo Finance10x Genomics BlogWhy 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance10x Genomics Blog10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News10x Genomics News10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology NewsScience Daily BiotechA rare cancer-fighting plant compound has been decodedEli LillyEli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - StocktwitseLifeExamining the role of lipids in hearingEndpoints NewsLilly points to low-dose Zepbound and Foundayo as weight loss maintenance optionsIlluminaThe Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st
10x Genomics Blog Mar 29, 2026

Is Ark Invest’s Steady Buying Reframing the Long-Term Product Expansion Story At 10x Genomics (TXG)? - simplywall.st

Is Ark Invest’s Steady Buying Reframing the Long-Term Product Expansion Story At 10x Genomics (TXG)? - simplywall.st

Original
Body unavailable. Use the original source.